Detection of Two Missense Mutations and Characterization of a Repeat Polymorphism in the Factor VII Gene (F7)

Overview

Journal Hum Genet

Specialty Genetics

Date 1992 Jul 1

PMID 1634227

Citations 11

Authors

G Marchetti

P Patracchini

D Gemmati

V DeRosa

M Pinotti

G Rodorigo

A Casonato

A Girolami

F Bernardi

Affiliations

Soon will be listed here.

Abstract

The 3' portion of the coagulation factor VII gene, containing the activation and serine protease domains, was investigated in four subjects with factor VII deficiency by temperature gradient gel electrophoresis and sequencing of polymerase chain reaction (PCR) products. Molecules displaying an altered melting behaviour were detected in three subjects, and direct sequencing showed two mutations. A G-to-T transversion causing a missense mutation, Cys-310 to Phe, suppresses a disulphide bond conserved in the catalytic domain of all serine proteases. This mutation, which in the homozygous form causes a severe reduction in protease activity (4%), was found in two patients from different Italian regions. A G-to-A transition, which gives rise to a missense mutation, Arg-304 to Gln, and is associated with the factor VII padua variant, was found in the heterozygous form in a subject also affected by von Willebrand disease. Two polymorphic alleles, which differ in one repeat monomer element, were precisely mapped in a region spanning the exon-intron 7 border of the factor VII gene and studied in families with factor VII or X deficiency.

Citing Articles

Molecular Genetic Analysis of Russian Patients with Coagulation Factor FVII Deficiency.

Pshenichnikova O, Selivanova D, Shchemeleva E, Abramova T, Zozulya N, Surin V Genes (Basel). 2023; 14(9).

PMID: 37761907 PMC: 10531009. DOI: 10.3390/genes14091767.

Extensive genetic screening of Iranian Factor FVII-deficient individuals unraveled several novel mutations and postulated founder effects in some cases.

Ravanbod S, Faranoush M, Changi-Ashtiani M, Rokni-Zadeh H, Shahani T Res Pract Thromb Haemost. 2023; 7(1):100003.

PMID: 36760778 PMC: 9903653. DOI: 10.1016/j.rpth.2022.100003.

Personalized approach of medication by indirect anticoagulants tailored to the patient-Russian context: what are the prospects?.

Belozerceva L, Voronina E, Kokh N, Tsvetovskay G, Momot A, Lifshits G EPMA J. 2012; 3(1):10.

PMID: 23016735 PMC: 3492156. DOI: 10.1186/1878-5085-3-10.

Association of ACE and FACTOR VII gene variability with the risk of coronary heart disease in north Indian population.

Sobti R, Maithil N, Thakur H, Sharma Y, Talwar K Mol Cell Biochem. 2010; 341(1-2):87-98.

PMID: 20364300 DOI: 10.1007/s11010-010-0440-7.

Oriented scanning is the leading mechanism underlying 5' splice site selection in mammals.

Borensztajn K, Sobrier M, Duquesnoy P, Fischer A, Tapon-Bretaudiere J, Amselem S PLoS Genet. 2006; 2(9):e138.

PMID: 16948532 PMC: 1557585. DOI: 10.1371/journal.pgen.0020138.

References

OHara P, Grant F . The human factor VII gene is polymorphic due to variation in repeat copy number in a minisatellite. Gene. 1988; 66(1):147-58. DOI: 10.1016/0378-1119(88)90232-6. View

Killen P, Francomano C, Yamada Y, Modi W, OBrien S . Partial structure of the human alpha 2(IV) collagen chain and chromosomal localization of the gene (COL4A2). Hum Genet. 1987; 77(4):318-24. DOI: 10.1007/BF00291418. View

de Grouchy J, Dautzenberg M, Turleau C, Beguin S . Regional mapping of clotting factors VII and X to 13q34. Expression of factor VII through chromosome 8. Hum Genet. 1984; 66(2-3):230-3. DOI: 10.1007/BF00286607. View

Bernardi F, Marchetti G, Guerra S, Casonato A, Gemmati D, Patracchini P . A de novo and heterozygous gene deletion causing a variant of von Willebrand disease. Blood. 1990; 75(3):677-83. View

Reiss J, Cooper D, Bal J, Slomski R, Cutting G, Krawczak M . Discrimination between recurrent mutation and identity by descent: application to point mutations in exon 11 of the cystic fibrosis (CFTR) gene. Hum Genet. 1991; 87(4):457-61. DOI: 10.1007/BF00197168. View

Myers R, Lumelsky N, LERMAN L, Maniatis T . Detection of single base substitutions in total genomic DNA. Nature. 1985; 313(6002):495-8. DOI: 10.1038/313495a0. View

Green P, Bentley D, MIBASHAN R, Nilsson I, Giannelli F . Molecular pathology of haemophilia B. EMBO J. 1989; 8(4):1067-72. PMC: 400915. DOI: 10.1002/j.1460-2075.1989.tb03474.x. View

Girolami A, Coser P, Brunetti A, Prinoth O . Classical factor X deficiency. Report of a further case. Acta Haematol. 1975; 53(2):118-27. DOI: 10.1159/000208165. View

Alexander B, Goldstein R, LANDWEHR G, Cook C . Congenital SPCA deficiency: a hitherto unrecognized coagulation defect with hemorrhage rectified by serum and serum fractions. J Clin Invest. 1951; 30(6):596-608. PMC: 436294. DOI: 10.1172/JCI102477. View

10.

Fischer S, LERMAN L . DNA fragments differing by single base-pair substitutions are separated in denaturing gradient gels: correspondence with melting theory. Proc Natl Acad Sci U S A. 1983; 80(6):1579-83. PMC: 393645. DOI: 10.1073/pnas.80.6.1579. View

11.

Rodeghiero F, Castaman G, Dini E . Epidemiological investigation of the prevalence of von Willebrand's disease. Blood. 1987; 69(2):454-9. View

12.

Seligsohn U, Osterud B, BROWN S, Griffin J, RAPAPORT S . Activation of human factor VII in plasma and in purified systems: roles of activated factor IX, kallikrein, and activated factor XII. J Clin Invest. 1979; 64(4):1056-65. PMC: 372216. DOI: 10.1172/JCI109543. View

13.

Rao L, RAPAPORT S . Factor VIIa-catalyzed activation of factor X independent of tissue factor: its possible significance for control of hemophilic bleeding by infused factor VIIa. Blood. 1990; 75(5):1069-73. View

14.

Girolami A, Cattarozzi G, Dal Bo Zanon R, Toffanin F . Factor VII Padua 2: another factor VII abnormality with defective ox brain thromboplastin activation and a complex hereditary pattern. Blood. 1979; 54(1):46-53. View

15.

Radcliffe R, Nemerson Y . Mechanism of activation of bovine factor VII. Products of cleavage by factor Xa. J Biol Chem. 1976; 251(16):4749-802. View

16.

Marchetti G, Gemmati D, Patracchini P, Pinotti M, Bernardi F . PCR detection of a repeat polymorphism within the F7 gene. Nucleic Acids Res. 1991; 19(16):4570. PMC: 328674. DOI: 10.1093/nar/19.16.4570-a. View

17.

Saiki R, Scharf S, Faloona F, Mullis K, Horn G, Erlich H . Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science. 1985; 230(4732):1350-4. DOI: 10.1126/science.2999980. View

18.

Hedner U, Kisiel W . Use of human factor VIIa in the treatment of two hemophilia A patients with high-titer inhibitors. J Clin Invest. 1983; 71(6):1836-41. PMC: 370389. DOI: 10.1172/jci110939. View

19.

Girolami A, Dal Bo Zanon R, Zanella F, Procidano M, Ruffato G . Factor VII Padua defect: the heterozygote population. Acta Haematol. 1982; 68(1):34-8. DOI: 10.1159/000206945. View

20.

Miller C, Hilgartner M, Harris M, Bussel J, Aledort L . Concurrence of von Willebrand's disease and hemophilia A: implications for carrier detection and prevalence. Am J Med Genet. 1986; 24(1):83-94. DOI: 10.1002/ajmg.1320240110. View